Analysis for Residual Solvents in Pharmaceuticals -JP18, USP467 : Class 2A Standard Solution

Significance of the Topic

Residual solvents in active pharmaceutical ingredients and finished products can compromise drug safety and efficacy. Regulatory guidelines such as ICH Q3C classify solvents based on toxicity and permissible daily exposure, making reliable determination of Class 2A solvents essential for quality control and patient safety.

Objectives and Study Overview

This application note demonstrates a headspace gas chromatography method combined with dual detection by flame ionization detector and mass spectrometry. The goal is to separate and quantify eighteen Class 2A residual solvents specified in JP18 and USP467 in a single 60-minute run, ensuring compliance with pharmacopeial standards.

Methodology and Used Instrumentation

The analysis employed a Shimadzu GCMS-QP2010 NX coupled to an HS-20 NX headspace sampler and an FID-2030. An SH-I-624Sil MS column (30 m × 0.32 mm I.D., 1.8 µm) provided separation. The GC oven was held at 40 °C for 20 min, ramped at 10 °C/min to 240 °C, and held for 20 min. Headspace conditions included 45 min equilibration at 80 °C, a vial pressurization of 75 kPa, and a 1 mL injection volume. FID was maintained at 250 °C with H2, air, and He make-up flows at 32, 200, and 24 mL/min respectively. MS parameters included ion source at 200 °C, interface at 250 °C, and scan range m/z 30–250 at 0.3 s event time.

Main Results and Discussion

All eighteen target solvents were baseline resolved within a 60-minute run. Mass spectrometric total ion chromatograms allowed unambiguous identification, while FID signals provided sensitive quantitation. Representative peaks such as methanol, dichloromethane, tetrahydrofuran, and toluene exhibited sharp Gaussian profiles, confirming column performance. The method demonstrated linear response, low detection limits, and reproducible retention times suitable for routine QC.

Benefits and Practical Applications

• Simultaneous determination of a broad panel of Class 2A solvents in one analysis.
• Dual detection enhances confidence in identification and quantitation.
• Compliance with pharmacopeial regulations for residual solvent testing.
• Robustness and reproducibility for high-throughput quality control laboratories.

Future Trends and Potential Applications

Advances in column technology could reduce analysis time and solvent consumption. Integration of automated data processing and library matching will streamline identification. Miniaturized or portable headspace-GC systems may enable on-site testing in manufacturing environments. Coupling with high-resolution mass spectrometry could further improve sensitivity for trace-level impurities.

Conclusion

The presented headspace GC-FID-MS method using Shimadzu instrumentation provides a reliable, sensitive, and pharmacopeia-compliant approach for residual solvent analysis in pharmaceuticals. Its combination of separation efficiency and dual detection ensures accurate monitoring of toxic solvents, supporting product safety and regulatory adherence.

References

ICH Q3C Impurities: Guidelines for Residual Solvents
JP18 and USP467 Class 2A Standard Solutions